未登录Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancerafatinib治疗前的血浆游离DNA甲基化谱与表皮生长因子受体基因突变阳性非小细胞肺癌患者的无进展生存期和总生存期相关
Fujimoto, Mao; Yasuda, Hiroyuki; Arai, Eri; Nakajima, Makoto; Takata, Saori; Morikawa, Kei; Tanaka, Hisashi; Itani, Hidetoshi; Honda, Takeshi; Horiuchi, Kazuya; Watanabe, Kageaki; Nakagawa, Hideyuki; Nakahara, Yoshiro; Seki, Yoshitaka; Bessho, Akihiro; Takahashi, Nobumasa; Hayashi, Kentaro; Endo, Takeo; Takeyama, Kiyoshi; Maekura, Toshiya; Takigawa, Nagio; Kawase, Akikazu; Endoh, Makoto; Nemoto, Kenji; Kishi, Kazuma; Soejima, Kenzo; Okuma, Yusuke; Togashi, Akira; Matsutani, Noriyuki; Seki, Nobuhiko; Kanai, Yae .png)
分享.png)
收藏分享 收藏 Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancerKaira, Kyoichi; Yamaguchi, Ou; Naruse, Ichiro; Umeda, Yukihiro; Honda, Takeshi; Watanabe, Satoshi; Ichikawa, Kosuke; Yanagisawa, Shin; Kasahara, Norimitsu; Higuchi, Tetsuya; Hashimoto, Kosuke; Miura, Yu; Shiono, Ayako; Mouri, Atsuto; Imai, Hisao; Iizuka, Kunihiko; Ishizuka, Tamotsu; Minato, Koichi; Suda, Satoshi; Kagamu, Hiroshi; Mori, Keita; Seki, Nobuhiko; Kuji, Ichiei 分享 收藏 分享 收藏 Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancerYamaguchi, Ou; Kaira, Kyoichi; Naruse, Ichiro; Umeda, Yukihiro; Honda, Takeshi; Watanabe, Satoshi; Ichikawa, Kosuke; Tateishi, Kazunari; Kasahara, Norimitsu; Higuchi, Tetsuya; Hashimoto, Kosuke; Shinomiya, Shun; Miura, Yu; Shiono, Ayako; Mouri, Atsuto; Imai, Hisao; Iizuka, Kunihiko; Ishizuka, Tamotsu; Minato, Koichi; Suda, Satoshi; Kagamu, Hiroshi; Mori, Keita; Kuji, Ichiei; Seki, Nobuhiko 分享 收藏 分享 收藏 分享 收藏 Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors in patients with advanced non-small cell lung cancerIshihara, Masashi; Ochiai, Ryosuke; Haruyama, Terunobu; Sakamoto, Takahiko; Tanzawa, Shigeru; Honda, Takeshi; Ota, Shuji; Ichikawa, Yasuko; Ishida, Tsuyoshi; Watanabe, Kiyotaka; Seki, Nobuhiko 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Pharmacokinetic and Pharmacodynamic Profiles of Glyco-Modified Atrial Natriuretic Peptide Derivatives Synthesized Using Chemo-enzymatic Synthesis ApproachesIwamoto, Mitsuhiro; Yamaguchi, Takahiro; Sekiguchi, Yukiko; Oishi, Shohei; Shiiki, Takeshi; Soma, Masako; Nakamura, Kensuke; Yoshida, Makoto; Chaya, Hiroyuki; Mori, Yutaka; Miyauchi, Ryuki; Hasegawa, Jun; Nagayama, Takahiro; Honda, Takeshi 分享 收藏 分享 收藏 Optimization of 3-aryl-3-ethoxypropanoic acids and discovery of the potent GPR40 agonist DS-1558Takano, Rieko; Yoshida, Masao; Inoue, Masahiro; Honda, Takeshi; Nakashima, Ryutaro; Matsumoto, Koji; Yano, Tatsuya; Ogata, Tsuneaki; Watanabe, Nobuaki; Hirouchi, Masakazu; Kimura, Takako; Toda, Narihiro 分享 收藏 分享 收藏 分享 收藏 Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 AgonistDS-1558的发现: 一种有效且可口服生物利用的GPR40激动剂Takano, Rieko; Yoshida, Masao; Inoue, Masahiro; Honda, Takeshi; Nakashima, Ryutaro; Matsumoto, Koji; Yano, Tatsuya; Ogata, Tsuneaki; Watanabe, Nobuaki; Hirouchi, Masakazu; Yoneyama, Tomoko; Ito, Shuichiro; Toda, Narihiro 分享 收藏 分享 收藏 Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonistsNakashima, Ryutaro; Yano, Tatsuya; Ogawa, Junko; Tanaka, Naomi; Toda, Narihiro; Yoshida, Masao; Takano, Rieko; Inoue, Masahiro; Honda, Takeshi; Kume, Shoen; Matsumoto, Koji 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
CLINICAL EPIGENETICS.png)
OAAI